Product image of Nebulgen Bambini (Flunisolide) supplied by GNH India

Nebulgen Bambini

Active Ingredient:
Flunisolide
Origin:
EU

Nebulgen Bambini (Flunisolide)

Flunisolide, the active ingredient in Nebulgen Bambini, is a corticosteroid presented as a nebulized solution for inhalation use. It reduces airway inflammation and hyper‑responsiveness, providing relief in asthma and, off‑label, chronic obstructive pulmonary disease for both children and adults.

GNH India supplies Nebulgen Bambini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide, ensuring quality‑controlled batches and reliable logistics for global markets. All shipments meet EU GMP standards and are accompanied by full documentation.

Manufacturer / TM Owner

I.B.N. Savio S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Flunisolide is an inhaled corticosteroid that acts on the inflammatory pathway of respiratory diseases.
  • Asthma: reduces airway inflammation and improves symptom control.
  • Chronic obstructive pulmonary disease (off‑label): helps decrease exacerbations and improves lung function.
  • Allergic airway disease: mitigates bronchial inflammation associated with allergic triggers.

How It Works

  • Flunisolide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the production of pro‑inflammatory cytokines, decreases eosinophil recruitment, and reduces airway edema, leading to lowered airway hyper‑responsiveness and improved airflow.

Side Effects

Flunisolide may cause a range of adverse reactions.

Common Side Effects

  • Throat irritation or soreness.
  • Hoarseness or dysphonia.
  • Cough during or after inhalation.
  • Oral candidiasis (thrush).
  • Headache.

Serious or Rare Side Effects

  • Adrenal suppression with prolonged high‑dose use.
  • Growth retardation in pediatric patients.
  • Severe allergic reactions such as anaphylaxis.
  • Pneumonia or other opportunistic infections.
  • Paradoxical bronchospasm.

Precautions & Warnings

  • Use Nebulgen Bambini with careful clinical monitoring.
  • Dose adjustment: employ the lowest effective dose to limit systemic exposure.
  • Monitor growth: pediatric patients should have regular height and weight assessments.
  • Avoid abrupt discontinuation: taper the dose after long‑term therapy to prevent adrenal insufficiency.
  • Use mouth rinse: rinse the mouth after inhalation to reduce risk of oral candidiasis.
  • Pregnancy and lactation: evaluate risk‑benefit with the prescriber as safety data are limited.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light in the original container.

Avoid Interactions

Flunisolide can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Systemic CYP3A4 inhibitors (e.g., ketoconazole) may raise systemic corticosteroid levels.
  • Strong immunosuppressants (e.g., azathioprine) increase risk of infection.
  • Live vaccines: heightened risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely)

  • Azole antifungals: may modestly increase exposure.
  • Ritonavir or other protease inhibitors: can elevate plasma concentrations.
  • Short‑acting β2‑agonists: may mask worsening asthma symptoms.

Frequently Asked Questions

Nebulgen Bambini is a nebulized solution containing flunisolide, an inhaled corticosteroid. It is prescribed to reduce airway inflammation in patients with asthma and, off‑label, in chronic obstructive pulmonary disease, helping to improve breathing and prevent exacerbations.

Flunisolide binds to glucocorticoid receptors inside airway cells, altering gene transcription. This reduces the release of inflammatory cytokines, limits eosinophil activity, and decreases airway swelling, which together lower airway hyper‑responsiveness and improve airflow.

The dose of Nebulgen Bambini is individualized by the prescribing clinician based on the patient’s age, severity of disease, and response to therapy. Specific dosing regimens are not provided here and should be obtained from the treating healthcare professional.

Safety data for flunisolide in pregnancy and lactation are limited, and the product does not have a definitive pregnancy category. Clinicians should weigh potential benefits against possible risks and discuss options with the patient before use.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nebulgen Bambini delivers flunisolide via nebulization, which can be advantageous for patients who have difficulty using metered‑dose inhalers. Compared with alternatives such as budesonide or fluticasone, flunisolide has a similar anti‑inflammatory potency but differs in particle size and delivery device, influencing onset of action and patient preference.

Store the nebulized solution at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use to maintain stability.

Nebulgen Bambini is administered by connecting the vial to a compatible nebulizer device, adding the prescribed volume to the nebulizer cup, and inhaling the aerosolized mist as directed by the healthcare provider. Patients should follow the device’s instructions for optimal delivery.

Serious adverse events include adrenal suppression with prolonged high‑dose use, growth retardation in children, severe allergic reactions such as anaphylaxis, opportunistic infections like pneumonia, and paradoxical bronchospasm. Any of these symptoms require immediate medical attention.

Nebulgen Bambini is contraindicated in individuals with known hypersensitivity to flunisolide or any component of the formulation. Caution is also advised for patients with active untreated infections, uncontrolled systemic fungal disease, or those receiving systemic corticosteroids where additive effects could be harmful.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Flunisolide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT